| The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage ASA Lila, H Kiwada, T Ishida Journal of Controlled Release 172 (1), 38-47, 2013 | 514 | 2013 |
| PEGylated liposomes: immunological responses M Mohamed, AS Abu Lila, T Shimizu, E Alaaeldin, A Hussein, HA Sarhan, ... Science and Technology of Advanced Materials 20 (1), 710-724, 2019 | 295 | 2019 |
| Liposomal delivery systems: design optimization and current applications ASA Lila, T Ishida Biological and pharmaceutical bulletin 40 (1), 1-10, 2017 | 295 | 2017 |
| Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model ASA Lila, S Kizuki, Y Doi, T Suzuki, T Ishida, H Kiwada Journal of controlled release 137 (1), 8-14, 2009 | 147 | 2009 |
| Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon … ASA Lila, K Nawata, T Shimizu, T Ishida, H Kiwada International journal of pharmaceutics 456 (1), 235-242, 2013 | 107 | 2013 |
| Targeting anticancer drugs to tumor vasculature using cationic liposomes AS Abu Lila, T Ishida, H Kiwada Pharmaceutical research 27, 1171-1183, 2010 | 103 | 2010 |
| Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model A Abu-Lila, T Suzuki, Y Doi, T Ishida, H Kiwada Journal of controlled release 134 (1), 18-25, 2009 | 82 | 2009 |
| A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA K Nakamura, ASA Lila, M Matsunaga, Y Doi, T Ishida, H Kiwada Molecular Therapy 19 (11), 2040-2047, 2011 | 80 | 2011 |
| Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor ASA Lila, Y Doi, K Nakamura, T Ishida, H Kiwada Journal of Controlled Release 142 (2), 167-173, 2010 | 74 | 2010 |
| Synthesis of gold nanoparticles by using green machinery: Characterization and in vitro toxicity A Al Saqr, ES Khafagy, A Alalaiwe, MF Aldawsari, SM Alshahrani, ... Nanomaterials 11 (3), 808, 2021 | 62 | 2021 |
| A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes T Shimizu, ASA Lila, R Fujita, M Awata, M Kawanishi, Y Hashimoto, ... European Journal of Pharmaceutics and Biopharmaceutics 127, 142-149, 2018 | 59 | 2018 |
| A novel strategy to increase the yield of exosomes (extracellular vesicles) for an expansion of basic research SE Emam, H Ando, ASA Lila, T Shimizu, M Ukawa, K Okuhira, Y Ishima, ... Biological and Pharmaceutical Bulletin 41 (5), 733-742, 2018 | 58 | 2018 |
| Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against … Y Hashimoto, T Shimizu, ASA Lila, T Ishida, H Kiwada Biological and Pharmaceutical Bulletin 38 (3), 417-424, 2015 | 50 | 2015 |
| Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery ASA Lila, Y Uehara, T Ishida, H Kiwada Journal of pharmaceutical sciences 103 (2), 557-566, 2014 | 47 | 2014 |
| Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity Y Mima, ASA Lila, T Shimizu, M Ukawa, H Ando, Y Kurata, T Ishida Journal of Controlled Release 250, 20-26, 2017 | 46 | 2017 |
| Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs Y Hashimoto, T Shimizu, Y Mima, ASA Lila, T Ishida, H Kiwada Toxicology and applied pharmacology 277 (1), 30-38, 2014 | 45 | 2014 |
| Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application ASA Lila, NE Eldin, M Ichihara, T Ishida, H Kiwada International journal of pharmaceutics 438 (1-2), 176-183, 2012 | 44 | 2012 |
| Pulmonary targeting of inhalable moxifloxacin microspheres for effective management of tuberculosis B Vishwa, A Moin, DV Gowda, SMD Rizvi, WAH Hegazy, AS Abu Lila, ... Pharmaceutics 13 (1), 79, 2021 | 42 | 2021 |
| Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues SE Emam, ASA Lila, NE Elsadek, H Ando, T Shimizu, K Okuhira, Y Ishima, ... European Journal of Pharmaceutics and Biopharmaceutics 145, 27-34, 2019 | 41 | 2019 |
| Recent advances in tumor vasculature targeting using liposomal drug delivery systems AS Abu Lila, T Ishida, H Kiwada Expert Opinion on Drug Delivery 6 (12), 1297-1309, 2009 | 41 | 2009 |
